TipRanks
Kyntra Bio (DE:1FG0)
FRANKFURT:1FG0
Germany Market
1FG0
Kyntra Bio
RESEARCH TOOLSreports

Kyntra Bio (1FG0) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

1FG0 Analyst Ratings

Strong Buy
4Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Kyntra
Bio
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1FG0 Stock 12 Month Forecast

Average Price Target

€35.02
▲(430.56% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Kyntra Bio in the last 3 months. The average price target is €35.02 with a high forecast of €37.96 and a low forecast of €30.90. The average price target represents a 430.56% change from the last price of €6.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"€4","21":"€21","38":"€38","12.5":"€12.5","29.5":"€29.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":37.959542150000004,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€37.96</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.01694198333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€35.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.89730175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€30.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,12.5,21,29.5,38],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.85,8.319964780769231,10.789929561538461,13.259894342307692,15.729859123076924,18.199823903846156,20.669788684615384,23.139753465384615,25.609718246153847,28.079683026923078,30.54964780769231,33.01961258846154,35.48957736923077,{"y":37.959542150000004,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.85,8.093610921794872,10.337221843589742,12.580832765384613,14.824443687179485,17.068054608974357,19.311665530769226,21.5552764525641,23.79888737435897,26.042498296153845,28.286109217948713,30.52972013974359,32.77333106153846,{"y":35.01694198333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.85,7.776715519230769,9.703431038461538,11.630146557692308,13.556862076923078,15.483577596153847,17.41029311538462,19.337008634615387,21.263724153846155,23.190439673076924,25.117155192307692,27.04387071153846,28.970586230769236,{"y":30.89730175,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.542,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.3,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.3,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.3,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.75,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.65,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.35,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.7,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.4,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.85,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€37.96Average Price Target€35.02Lowest Price Target€30.90
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on DE:1FG0
Daniel Brims
Lake Street
Lake Street
€36.19
Buy
448.39%
Upside
Initiated
09/17/26
Kyntra Bio initiated with a Buy at Lake StreetKyntra Bio initiated with a Buy at Lake Street
H.C. Wainwright Analyst forecast on DE:1FG0
Matthew Keller
H.C. Wainwright
H.C. Wainwright
€37.96
Buy
475.14%
Upside
Reiterated
09/01/26
Analysts' Top Healthcare Picks: Kyntra Bio (KYNB), Arrowhead Pharmaceuticals (ARWR)
William Blair Analyst forecast on DE:1FG0
Andy Hsieh
William Blair
William Blair
―
Hold
―
Reiterated
08/31/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Oppenheimer Analyst forecast on DE:1FG0
Jay Olson
Oppenheimer
Oppenheimer
€30.9
Buy
368.14%
Upside
Reiterated
08/14/26
Oppenheimer Keeps Their Buy Rating on Kyntra Bio (KYNB)
Rodman & Renshaw Analyst forecast on DE:1FG0
Michael King
Rodman & Renshaw
Rodman & Renshaw
€26.48
Buy
301.26%
Upside
Initiated
06/09/26
Kyntra Bio initiated with a Buy at Rodman & RenshawKyntra Bio initiated with a Buy at Rodman & Renshaw
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on DE:1FG0
Daniel Brims
Lake Street
Lake Street
€36.19
Buy
448.39%
Upside
Initiated
09/17/26
Kyntra Bio initiated with a Buy at Lake StreetKyntra Bio initiated with a Buy at Lake Street
H.C. Wainwright Analyst forecast on DE:1FG0
Matthew Keller
H.C. Wainwright
H.C. Wainwright
€37.96
Buy
475.14%
Upside
Reiterated
09/01/26
Analysts' Top Healthcare Picks: Kyntra Bio (KYNB), Arrowhead Pharmaceuticals (ARWR)
William Blair Analyst forecast on DE:1FG0
Andy Hsieh
William Blair
William Blair
―
Hold
―
Reiterated
08/31/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Oppenheimer Analyst forecast on DE:1FG0
Jay Olson
Oppenheimer
Oppenheimer
€30.9
Buy
368.14%
Upside
Reiterated
08/14/26
Oppenheimer Keeps Their Buy Rating on Kyntra Bio (KYNB)
Rodman & Renshaw Analyst forecast on DE:1FG0
Michael King
Rodman & Renshaw
Rodman & Renshaw
€26.48
Buy
301.26%
Upside
Initiated
06/09/26
Kyntra Bio initiated with a Buy at Rodman & RenshawKyntra Bio initiated with a Buy at Rodman & Renshaw
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OMCLOmnicell
KNSAKiniksa Pharmaceuticals
ACHVAchieve Life Sciences
AHCOAdaptHealth
ZVRAZevra Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kyntra Bio

3 Months
Matthew KellerH.C. Wainwright
Success Rate
4/12 ratings generated profit
33%
Average Return
-8.71%
Copying Matthew Keller's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -8.71% per trade.
1 Year
Matthew KellerH.C. Wainwright
Success Rate
0/12 ratings generated profit
0%
Average Return
-15.34%
Copying Matthew Keller's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -15.34% per trade.
2 Years
Matthew KellerH.C. Wainwright
Success Rate
0/12 ratings generated profit
0%
Average Return
-19.58%
Copying Matthew Keller's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -19.58% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1FG0 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
2
3
4
5
4
Buy
0
0
0
0
0
Hold
1
1
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
4
6
7
6
In the current month, 1FG0 has received 4 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 1FG0 average Analyst price target in the past 3 months is 35.02.
Each month's total comprises the sum of three months' worth of ratings.

1FG0 Financial Forecast

1FG0 Earnings Forecast

Next quarter’s earnings estimate for 1FG0 is -€3.29 with a range of -€3.80 to -€2.58. The previous quarter’s EPS was €2.61. 1FG0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1FG0 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1FG0 is -€3.29 with a range of -€3.80 to -€2.58. The previous quarter’s EPS was €2.61. 1FG0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1FG0 has Performed in-line its overall industry.

1FG0 Sales Forecast

Next quarter’s sales forecast for 1FG0 is €1.62M with a range of €1.04M to €3.00M. The previous quarter’s sales results were -€1.30M. 1FG0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1FG0 has Performed in-line its overall industry.
Next quarter’s sales forecast for 1FG0 is €1.62M with a range of €1.04M to €3.00M. The previous quarter’s sales results were -€1.30M. 1FG0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1FG0 has Performed in-line its overall industry.

1FG0 Stock Forecast FAQ

What is DE:1FG0’s average 12-month price target, according to analysts?
Based on analyst ratings, Kyntra Bio’s 12-month average price target is 35.02.
    What is DE:1FG0’s upside potential, based on the analysts’ average price target?
    Kyntra Bio has 430.56% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Kyntra Bio a Buy, Sell or Hold?
          Kyntra Bio has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Kyntra Bio’s share price target?
            The average share price target for Kyntra Bio is 35.02. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €37.96 ,and the lowest forecast is €30.90. The average share price target represents 430.56% Increase from the current price of €6.6.
              What do analysts say about Kyntra Bio?
              Kyntra Bio’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Kyntra Bio?
                To buy shares of DE:1FG0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.